What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Neuron
The scientist’s investigation covers issues in Neuroscience, Cholinergic, Internal medicine, Endocrinology and Alzheimer's disease.
The Neuroscience study combines topics in areas such as Long-term potentiation, Glutamatergic and Dementia.
His work carried out in the field of Cholinergic brings together such families of science as Cerebral cortex, GABAergic, Acetylcholine and Neurotrophin.
His Alzheimer's disease research is multidisciplinary, relying on both Transgene, Microglia, Degenerative disease, Neuroinflammation and Amyloid.
His study explores the link between Central nervous system and topics such as Hypothalamus that cross with problems in Substance P.
His Basal forebrain study integrates concerns from other disciplines, such as Nerve growth factor, Amyloid precursor protein and Cholinergic neuron.
His most cited work include:
- The distribution of substance P immunoreactive fibers in the rat central nervous system (694 citations)
- Translational control of hippocampal synaptic plasticity and memory by the eIF2α kinase, GCN2 (319 citations)
- The central and peripheral ends of the substance P-containing sensory neurones in the rat trigeminal system. (314 citations)
What are the main themes of his work throughout his whole career to date?
A. Claudio Cuello spends much of his time researching Neuroscience, Internal medicine, Endocrinology, Nerve growth factor and Cholinergic.
His studies in Neuroscience integrate themes in fields like Disease and Transgene.
His work on Cognitive decline and Biomarker as part of general Internal medicine research is often related to Neuroserpin, thus linking different fields of science.
In his work, Neuroinflammation is strongly intertwined with Amyloid precursor protein, which is a subfield of Endocrinology.
A. Claudio Cuello combines subjects such as Lesion, Neurotrophic factors, Neurotrophin, Central nervous system and Atrophy with his study of Nerve growth factor.
The study incorporates disciplines such as Tropomyosin receptor kinase A, Acetylcholine and In vivo in addition to Cholinergic.
He most often published in these fields:
- Neuroscience (50.25%)
- Internal medicine (22.17%)
- Endocrinology (21.18%)
What were the highlights of his more recent work (between 2016-2021)?
- Neuroscience (50.25%)
- Disease (14.29%)
- Hippocampal formation (7.88%)
In recent papers he was focusing on the following fields of study:
A. Claudio Cuello mainly focuses on Neuroscience, Disease, Hippocampal formation, Internal medicine and Endocrinology.
His research in Neuroscience is mostly concerned with Hippocampus.
His Disease research integrates issues from Oxidative stress, Bioinformatics, Immunology, Neuroimaging and Down syndrome.
His study in the fields of Cholinergic under the domain of Endocrinology overlaps with other disciplines such as Neuroserpin and Bioenergetics.
A. Claudio Cuello works mostly in the field of Cholinergic, limiting it down to topics relating to Cerebral cortex and, in certain cases, Downregulation and upregulation.
His research integrates issues of Atrophy and Cholinergic neuron in his study of Neurodegeneration.
Between 2016 and 2021, his most popular works were:
- The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. (238 citations)
- Early and Late CNS Inflammation in Alzheimer’s Disease: Two Extremes of a Continuum? (61 citations)
- Precision pharmacology for Alzheimer's disease (52 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Neuron
His primary areas of study are Neuroscience, Cognitive decline, Internal medicine, Dementia and Hippocampal formation.
His Neuroscience research includes elements of Transgene, Pathogenesis, Proteomics, Quantitative proteomics and Amyloidosis.
His research in Cognitive decline intersects with topics in Retrospective cohort study, Basal forebrain, Cholinergic neuron, Asymptomatic and Montreal Cognitive Assessment.
His work investigates the relationship between Cholinergic neuron and topics such as Donepezil that intersect with problems in Nerve growth factor.
As part of his studies on Internal medicine, A. Claudio Cuello frequently links adjacent subjects like Endocrinology.
His biological study spans a wide range of topics, including Amyloid beta, Cholinergic, Biochemistry of Alzheimer's disease, BACE1-AS and Neuroinflammation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
